Analysts: Dell Earnings May Get Pressured and 4 New Opinions Investors Must Take a Peek At

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Cynosure, Inc. (NASDAQ:CYNO): According to Leerink, the 8 percent pullback in Cynosure (NASDAQ:CYNO) shares since the company’s Palomar Medical (NASDAQ:PMTI) takeover announcement on March 15 creates a buying opportunity, and the firm views the deal’s synergy benefits as underappreciated. The firm also thinks that the current share price prices are in integration risk. Leerink reiterates its Outperform rating and a $36 price target on the stock.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

CYNO

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business